Active Ingredient: ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
Proprietary Name: MYFEMBREE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG;0.5MG;40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214846
Product Number: 001
Approval Date: May 26, 2021
Applicant Holder Full Name: SUMITOMO PHARMA SWITZERLAND GMBH
Marketing Status:
Prescription
Patent and Exclusivity Information
